Home > Publications database > Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment. > print

001     290040
005     20250206113408.0
024 7 _ |a 10.1186/s12966-024-01601-x
|2 doi
024 7 _ |a pmid:38698447
|2 pmid
024 7 _ |a pmc:PMC11067118
|2 pmc
024 7 _ |a altmetric:163069170
|2 altmetric
037 _ _ |a DKFZ-2024-00945
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Chong, Marvin Y
|b 0
245 _ _ |a Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment.
260 _ _ |a London
|c 2024
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1715068300_19505
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a There is a growing population of survivors of colorectal cancer (CRC). Fatigue and insomnia are common symptoms after CRC, negatively influencing health-related quality of life (HRQoL). Besides increasing physical activity and decreasing sedentary behavior, the timing and patterns of physical activity and rest over the 24-h day (i.e. diurnal rest-activity rhythms) could also play a role in alleviating these symptoms and improving HRQoL. We investigated longitudinal associations of the diurnal rest-activity rhythm (RAR) with fatigue, insomnia, and HRQoL in survivors of CRC.In a prospective cohort study among survivors of stage I-III CRC, 5 repeated measurements were performed from 6 weeks up to 5 years post-treatment. Parameters of RAR, including mesor, amplitude, acrophase, circadian quotient, dichotomy index, and 24-h autocorrelation coefficient, were assessed by a custom MATLAB program using data from tri-axial accelerometers worn on the upper thigh for 7 consecutive days. Fatigue, insomnia, and HRQoL were measured by validated questionnaires. Confounder-adjusted linear mixed models were applied to analyze longitudinal associations of RAR with fatigue, insomnia, and HRQoL from 6 weeks until 5 years post-treatment. Additionally, intra-individual and inter-individual associations over time were separated.Data were available from 289 survivors of CRC. All RAR parameters except for 24-h autocorrelation increased from 6 weeks to 6 months post-treatment, after which they remained relatively stable. A higher mesor, amplitude, circadian quotient, dichotomy index, and 24-h autocorrelation were statistically significantly associated with less fatigue and better HRQoL over time. A higher amplitude and circadian quotient were associated with lower insomnia. Most of these associations appeared driven by both within-person changes over time and between-person differences in RAR parameters. No significant associations were observed for acrophase.In the first five years after CRC treatment, adhering to a generally more active (mesor) and consistent (24-h autocorrelation) RAR, with a pronounced peak activity (amplitude) and a marked difference between daytime and nighttime activity (dichotomy index) was found to be associated with lower fatigue, lower insomnia, and a better HRQoL. Future intervention studies are needed to investigate if restoring RAR among survivors of CRC could help to alleviate symptoms of fatigue and insomnia while enhancing their HRQoL.EnCoRe study NL6904 ( https://www.onderzoekmetmensen.nl/ ).
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Colorectal cancer survivorship
|2 Other
650 _ 7 |a Diurnal rest-activity rhythms
|2 Other
650 _ 7 |a Fatigue
|2 Other
650 _ 7 |a Health-related quality of life
|2 Other
650 _ 7 |a Insomnia
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Sleep Initiation and Maintenance Disorders: therapy
|2 MeSH
650 _ 2 |a Quality of Life
|2 MeSH
650 _ 2 |a Colorectal Neoplasms
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Fatigue
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Circadian Rhythm: physiology
|2 MeSH
650 _ 2 |a Cancer Survivors: psychology
|2 MeSH
650 _ 2 |a Rest
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Longitudinal Studies
|2 MeSH
650 _ 2 |a Exercise
|2 MeSH
650 _ 2 |a Surveys and Questionnaires
|2 MeSH
700 1 _ |a Frenken, Koen G
|b 1
700 1 _ |a Eussen, Simone J P M
|b 2
700 1 _ |a Koster, Annemarie
|b 3
700 1 _ |a Pot, Gerda K
|b 4
700 1 _ |a Breukink, Stéphanie O
|b 5
700 1 _ |a Janssen-Heijnen, Maryska
|b 6
700 1 _ |a Keulen, Eric T P
|b 7
700 1 _ |a Bijnens, Wouter
|b 8
700 1 _ |a Buffart, Laurien M
|b 9
700 1 _ |a Meijer, Kenneth
|b 10
700 1 _ |a Scheer, Frank A J L
|b 11
700 1 _ |a Steindorf, Karen
|0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
|b 12
|u dkfz
700 1 _ |a de Vos-Geelen, Judith
|b 13
700 1 _ |a Weijenberg, Matty P
|b 14
700 1 _ |a van Roekel, Eline H
|b 15
700 1 _ |a Bours, Martijn J L
|b 16
773 _ _ |a 10.1186/s12966-024-01601-x
|g Vol. 21, no. 1, p. 51
|0 PERI:(DE-600)2134691-4
|n 1
|p 51
|t International journal of behavioral nutrition and physical activity
|v 21
|y 2024
|x 1479-5868
856 4 _ |u https://inrepo02.dkfz.de/record/290040/files/s12966-024-01601-x.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/290040/files/s12966-024-01601-x.pdf?subformat=pdfa
|x pdfa
856 4 _ |u https://inrepo02.dkfz.de/record/290040/files/s13045-024-01562-5.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/290040/files/s13045-024-01562-5.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:290040
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J BEHAV NUTR PHY : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-04-12T15:07:28Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-04-12T15:07:28Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-04-12T15:07:28Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-29
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-29
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J BEHAV NUTR PHY : 2022
|d 2023-08-29
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-29
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-29
920 1 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Präventionsforschung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C110-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21